This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Somryst (Pear Therapeutics Inc.) for the treatment of chronic insomnia in adults.
If you have a Hayes login, click here to view the full report on the Knowledge Center.